Sol Invictus
08-06-2009, 12:07 PM
Reuters
July 23, 2009
The U.S. government has bought 195 million doses of H1N1 swine flu vaccine for a possible autumn vaccination campaign, a U.S. federal official said Thursday.
The U.S. Health and Human Services Department has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the department’s Dr. Robin Robinson told a meeting of Food and Drug Administration advisers.
Five companies are making H1N1 vaccine for the U.S. market — AstraZeneca’s MedImmune unit, Australia’s CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.
Earlier, an FDA official said vaccine makers were only getting about 30 percent as much vaccine from eggs as they usually get with seasonal influenza vaccine.
Read entire article (http://health.yahoo.com/news/reuters/us_flu_vaccine_hhs.html)
July 23, 2009
The U.S. government has bought 195 million doses of H1N1 swine flu vaccine for a possible autumn vaccination campaign, a U.S. federal official said Thursday.
The U.S. Health and Human Services Department has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the department’s Dr. Robin Robinson told a meeting of Food and Drug Administration advisers.
Five companies are making H1N1 vaccine for the U.S. market — AstraZeneca’s MedImmune unit, Australia’s CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.
Earlier, an FDA official said vaccine makers were only getting about 30 percent as much vaccine from eggs as they usually get with seasonal influenza vaccine.
Read entire article (http://health.yahoo.com/news/reuters/us_flu_vaccine_hhs.html)